Cali Pharmaceuticals Llc
Clinical trials sponsored by Cali Pharmaceuticals Llc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to ease pain after bunion surgery Results expected Oct 2026 (estimated)
-
New shot could cut opioid use after bunion surgery
Symptom relief CompletedThis study tested an experimental long-acting local anesthetic called CPL-01 in 616 people having bunion surgery. The goal was to see if it reduces pain and the need for opioid painkillers after the operation compared to a standard anesthetic or a placebo. Participants received t…
Phase 3 • Sponsor: Cali Pharmaceuticals LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New painkiller injection could ease recovery after hernia repair
Symptom relief CompletedThis study tested a new local anesthetic called CPL-01 to control pain after open inguinal hernia repair. 518 adults received either CPL-01, a placebo, or an active control injection right after surgery. Researchers measured pain levels during activity over time to see if CPL-01 …
Phase 3 • Sponsor: Cali Pharmaceuticals LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New pain drug shows promise in small tummy tuck study
Symptom relief CompletedThis Phase 2a study tested an experimental drug called CPL-01 in 20 people who had mini-abdominoplasty (a type of tummy tuck). The goal was to see if the drug is safe and how it behaves in the body after surgery. Participants received either CPL-01 or a placebo, and researchers m…
Phase 2 • Sponsor: Cali Pharmaceuticals LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC